Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-065916
Filing Date
2022-05-27
Accepted
2022-05-27 16:18:33
Documents
1
Period of Report
2022-05-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2217184-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2217184-6_4seq1.xml 4 7152
  Complete submission text file 0001104659-22-065916.txt   8584
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 22977790

Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations